Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 01)
Varenicline Tablet, Film Coated
Product Images NDC 70748-128
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 70748-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 02)
Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 03)
This text provides information about the medication regimen of Vareicin Tablet 10 mg to be taken twice daily as well as a placebo. The text also includes codes or identifiers such as B13, WU, W6, W, BN, OB, MR, 6%, 240. Additionally, it mentions a non-treatment follow-up period of a certain number of weeks.*
Image (5f079949 4bdb 4c58 9608 31d9599f9a0b 04)
This text provides information about a medication regimen, including Vareicin tablets at a dose of 10 mg twice a day compared to a placebo. It also mentions a treatment duration and a follow-up period. The specific details of the treatment and follow-up are not clearly provided.*
0.5 mg (5f079949 4bdb 4c58 9608 31d9599f9a0b 05)
This text provides information about a medication manufactured by Lupin Pharmaceuticals. The medication is in the form of coated tablets containing varenicline tartrate. It includes details such as dosage, storage guidelines, and instructions for dispensing in tight, child-resistant containers. The text also mentions that each tablet contains 0.85 mg varenicline tartrate equivalent to 0.5 mg varenicline free base. The location of manufacturing is in India, and there is a medication guide that should be dispensed to each patient along with the tablets.*
Figure 1 (5f079949 4bdb 4c58 9608 31d9599f9a0b 06)
This text contains information about a medication with NDC 70748-128-49, which is a tablet containing 1.71 mg of varenicline tartrate (equivalent to 1 mg varenicline) used for smoking cessation. The tablets are manufactured by Lupin Limited in India and should be stored at 15-30°C. Pharmacists are advised to dispense the medication guide separately to each patient. The prescription is for 56 tablets.*
Figure 2 (5f079949 4bdb 4c58 9608 31d9599f9a0b 07)
Figure 3 (5f079949 4bdb 4c58 9608 31d9599f9a0b 08)
Figure 4 (5f079949 4bdb 4c58 9608 31d9599f9a0b 09)
Figure 5 (5f079949 4bdb 4c58 9608 31d9599f9a0b 10)
Figure 6 (5f079949 4bdb 4c58 9608 31d9599f9a0b 11)
This is a description of varenicline tablets containing 0.85 mg and 1.71 mg of varenicline tartrate, which is equivalent to 0.5 mg and 1 mg of varenicline free base, respectively. The dosage instructions are detailed, with a schedule from Day 1 to Day 28 for taking the tablets. The storage conditions are provided, with a range of permitted temperatures for storage. The manufacturer is Lupin Pharmaceuticals, Inc., with locations in Baltimore, Maryland, and Pithampur, India. Additionally, information on the packaging, usage, and distribution of the medication is included. Refer to the accompanying Medication Guide for more details.*
Figure 7 (5f079949 4bdb 4c58 9608 31d9599f9a0b 12)
The text provides detailed information about varenicline tablets. It includes the dosage instructions for the first 28 days, specifying the amount of varenicline tartrate and free base in each tablet. The instructions outline a gradual increase in dosage over the first week and maintenance dosage thereafter. The text also mentions the storage conditions and emphasizes the need to keep the medication out of reach of children. Additionally, it indicates that the medication guide should be provided separately to each patient.*
Figure 8 (5f079949 4bdb 4c58 9608 31d9599f9a0b 13)
Each film-coated tablet contains 1.71 mg varenicline tartrate equivalent to 1 mg varenicline free base. The recommended dosage is to take one 1 mg tablet in the morning and one 1 mg tablet in the evening. It is important to refer to the accompanying Medication Guide for further information. It is advised to store the medication at room temperature but away from children. The product is manufactured for Lupin Pharmaceuticals, Inc. by Lupin Limited. Pharmacies are advised to dispense the Medication Guide with the tablets to each patient individually. The packaging is not child-resistant and intended for households without young children.*
Figure 9 (5f079949 4bdb 4c58 9608 31d9599f9a0b 14)
Each film-coated tablet of this medication contains 1.71 mg of varenicline tartrate, which is equivalent to 1 mg of varenicline free base. The recommended dosage is to take one 1 mg tablet in the morning and one 1 mg tablet in the evening. It is essential to store this medication at 25°C (77°F), with excursions permitted between 15°C to 30°C (59°F to 86°F). Make sure to keep this and all medications out of reach of children. The medication guide provides additional information. This medication is manufactured by Lupin Limited in India for Lupin Pharmaceuticals, Inc. in the United States.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
